cardiology
Arrhythmia

Selecting patients for idarucizumab (‘Praxbind’)

Sponsored by Boehringer Ingelheim Pty Ltd

In the final video of the series Professor Pollack takes us through interim results from RE-VERSE AD which identified the types of patients suitable for dabigatran reversal with idarucizumab (Praxbind).   

Already a member?

Login to keep reading.


OR
© 2021 the limbic